Showing results (1911-1920 of 8,878) with videos related to

Sort By:
Pageof 888
BJU International|October 11, 2012
Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancerNoel W Clarke
BJU International|October 11, 2012
Simultaneous implantation of bilateral ureters into bladder acellular matrix graft after partial cystectomy in a porcine modelYozo Mitsui, Hiroaki Shiina, Takeo Hiraoka, et al.
BJU International|October 11, 2012
Laparoscopic transvesical excision and reconstruction in the management of mid-urethral tape mesh erosion and stones around the bladder neck: initial experiencesJae Heon Kim, Seung Whan Doo, Won Jae Yang, et al.
BJU International|October 6, 2012
Principal component analysis based pre-cystectomy model to predict pathological stage in patients with clinical organ-confined bladder cancerHamed Ahmadi, Anirban P Mitra, George A Abdelsayed, et al.
BJU International|August 17, 2022
Cost-utility analysis of shockwave lithotripsy vs ureteroscopic stone treatment in adultsMary M Kilonzo, Ranan Dasgupta, Ruth Thomas, et al.
BJU International|June 20, 2020
The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational studyBernardo Rocco, Maria Chiara Sighinolfi, Marco Sandri, et al.
BJU International|February 23, 2023
Teaching robotic cystectomy: prospective pilot clinical validation of the ERUS training curriculumRomain Diamand, Frederiek D'Hondt, Georges Mjaess, et al.
BJU International|March 3, 2023
Same-day discharge robot-assisted laparoscopic prostatectomy: feasibility, safety and patient experienceGeorge Thomas Hill, Mekha Jeyanthi, William Coomer, et al.
BJU International|May 7, 2021
Assessment of prostate-specific antigen screening: an evidence-based report by the German Institute for Quality and Efficiency in Health CareUlrike Paschen, Sibylle Sturtz, Daniel Fleer, et al.
BJU International|May 7, 2021
A phase I open label dose-escalation study to evaluate the tolerability, safety and immunological efficacy of sub-urothelial durvalumab injection in adults with muscle-invasive or high-risk non-muscle-invasive bladder cancer (SUBDUE-1, SUB-urothelial DUrvalumab injection-1 study): clinical trial protocolAndrew Moe, Elizabeth Liow, Andrew Redfern, et al.
Pageof 888